Agilent Technologies Inc (NYSE:A) SVP Michael Tang sold 6,728 shares of the stock in a transaction that occurred on Wednesday, March 27th. The shares were sold at an average price of $80.50, for a total transaction of $541,604.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
Shares of A traded up $0.74 during mid-day trading on Friday, reaching $76.17. The stock had a trading volume of 2,874,195 shares, compared to its average volume of 1,737,020. The company has a current ratio of 3.39, a quick ratio of 2.79 and a debt-to-equity ratio of 0.36. Agilent Technologies Inc has a 52-week low of $60.42 and a 52-week high of $82.27. The firm has a market capitalization of $24.19 billion, a P/E ratio of 27.30, a P/E/G ratio of 2.12 and a beta of 1.38.
Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, February 20th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.73 by $0.03. The firm had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.27 billion. Agilent Technologies had a net margin of 22.86% and a return on equity of 19.90%. Agilent Technologies’s quarterly revenue was up 6.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.66 earnings per share. Equities research analysts predict that Agilent Technologies Inc will post 3.06 earnings per share for the current fiscal year.
A number of analysts have recently issued reports on the stock. Needham & Company LLC began coverage on shares of Agilent Technologies in a research note on Wednesday, January 2nd. They issued a “buy” rating and a $77.00 price objective for the company. UBS Group started coverage on shares of Agilent Technologies in a research note on Friday, March 15th. They issued a “buy” rating and a $92.00 price objective for the company. Alembic Global Advisors lowered shares of Agilent Technologies to a “hold” rating in a report on Monday, December 31st. Deutsche Bank lifted their price objective on shares of Agilent Technologies from $80.00 to $85.00 and gave the company a “buy” rating in a report on Tuesday, February 12th. Finally, Cowen lifted their price objective on shares of Agilent Technologies from $80.00 to $90.00 and gave the stock an “outperform” rating in a research report on Tuesday, March 26th. Two research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $87.17.
A number of hedge funds have recently made changes to their positions in A. Captrust Financial Advisors lifted its position in shares of Agilent Technologies by 2,121.1% during the fourth quarter. Captrust Financial Advisors now owns 422 shares of the medical research company’s stock worth $29,000 after purchasing an additional 403 shares in the last quarter. Lake Point Wealth Management acquired a new stake in shares of Agilent Technologies during the fourth quarter worth about $30,000. JOYN Advisors Inc. lifted its position in shares of Agilent Technologies by 186.6% during the fourth quarter. JOYN Advisors Inc. now owns 470 shares of the medical research company’s stock worth $32,000 after purchasing an additional 306 shares in the last quarter. We Are One Seven LLC acquired a new stake in shares of Agilent Technologies during the fourth quarter worth about $33,000. Finally, Truehand Inc acquired a new stake in shares of Agilent Technologies during the fourth quarter worth about $33,000.
TRADEMARK VIOLATION NOTICE: This article was first posted by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this article on another site, it was illegally copied and reposted in violation of United States and international copyright legislation. The legal version of this article can be read at https://www.baseballdailydigest.com/news/2019/04/21/michael-tang-sells-6728-shares-of-agilent-technologies-inc-a-stock.html.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Recommended Story: What are municipal bonds?
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.